ArticlePharmaceuticals (Basel, Switzerland)2022

Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells.

Futoon Abedrabbu Al-Rawashde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.